I now have all the content I need from Park's screening chapter. Let me compile a complete, structured teaching guide.
📚 Park's Screening Chapter - Complete Study Guide
(Park's Textbook of Preventive and Social Medicine)
1. CONCEPT OF SCREENING
Definition (memorise this verbatim):
"The search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy individuals."
Background - Iceberg Phenomenon:
The submerged part of the iceberg = hidden mass of disease (sub-clinical cases, carriers, undiagnosed cases). The floating tip = what the physician sees in practice. Screening targets the hidden part.
Why screening was developed:
- Annual health exams were too costly and time-consuming for large populations
- Screening conserves physician-time - technicians administer tests, physician only interprets
- Original programmes: TB, syphilis, antenatal mothers, school children, occupational groups
How screening differs from periodic health examination:
- Capable of wide application
- Relatively inexpensive
- Requires little physician-time (physician not needed to administer - only to interpret)
2. SCREENING vs. DIAGNOSTIC TESTS (Table - Very Exam Important)
| Screening Test | Diagnostic Test |
|---|
| Done on apparently healthy | Done on sick / those with indications |
| Applied to groups | Applied to single patients |
| Test results are arbitrary and final | Diagnosis modified by new evidence |
| Based on one criterion/cut-off point | Based on multiple symptoms, signs, labs |
| Less accurate | More accurate |
| Less expensive | More expensive |
| Not a basis for treatment | Used as basis for treatment |
| Initiative from investigator/agency | Initiative from patient with a complaint |
Note: The same test can sometimes be used for both screening AND diagnosis (e.g., VDRL for syphilis).
3. CASE-FINDING (Important distinction)
Definition: "The application of a diagnostic test, or a group of tests, to apparently healthy individuals who are consulting a physician for some other purpose."
Also called opportunistic screening - physician uses the patient's visit for another reason to screen them.
Examples: Random blood sugar check while patient is being treated for hypertension; urine test for proteinuria during a routine visit.
4. USES OF SCREENING (4 main uses)
a. Case Detection (Prescriptive Screening)
- Presumptive identification of unrecognized disease
- Does NOT arise from a patient's request
- People screened primarily for their own benefit
- Examples: neonatal screening, bacteriuria in pregnancy, breast cancer, cervical cancer, PKU, pulmonary TB, haemolytic disease of newborn
b. Control of Disease (Prospective Screening)
- People examined for the benefit of others
- Examples: screening immigrants for TB and syphilis to protect the home population; screening for streptococcal infection to prevent rheumatic fever
- Can reduce spread of infectious disease and/or mortality
c. Research Purposes
- To study the natural history of diseases whose course is not fully known (e.g., cancer, hypertension)
- Initial screening = prevalence estimate
- Subsequent screening = incidence figure
- Investigator has ethical obligation to treat those found positive
d. Syndromic Surveillance
- Screening populations to detect disease outbreaks early (e.g., influenza-like illness trends)
5. TYPES OF SCREENING (Very Important for MCQs)
a. Mass Screening
- Screening of whole population regardless of risk
- Example: Universal newborn screening for PKU/hypothyroidism
- Advantage: No one is missed
- Disadvantage: Expensive, many low-risk individuals screened unnecessarily
b. Selective / High-Risk Screening
- Screening only the high-risk group (a subgroup of the population)
- More cost-effective than mass screening
- Example: Screening only smokers for lung cancer; screening only hypertensives for target organ damage
- Also called "targeted screening"
c. Multiphasic Screening
- Application of two or more screening tests simultaneously to a large population
- Example: Measuring BP + blood glucose + cholesterol + vision in a single visit
- Advantage: More diseases detected in one contact; cost-effective per person
- Used extensively in health camps and industrial health programmes
6. CRITERIA FOR SCREENING (Wilson & Jungner Criteria - Most Important)
A disease/condition is suitable for screening if:
- The condition sought should be an important health problem (significant morbidity/mortality)
- There should be an accepted treatment for patients with recognized disease
- Facilities for diagnosis and treatment should be available
- There should be a recognizable latent or early symptomatic stage
- A suitable test or examination should be available - acceptable to the population
- The natural history of the condition should be adequately understood
- There should be an agreed policy on whom to treat as patients
- The cost of case-finding (including diagnosis and treatment) should be economically balanced in relation to possible expenditure on medical care as a whole
- Case-finding should be a continuing process and not a "once and for all" project
Memory trick: IACTNACS (Important, Accepted treatment, Cost, Treatment facilities, Natural history, Agreed policy, Continuing process, Suitable test)
7. VALIDITY OF SCREENING TESTS
Validity: The ability of a test to distinguish those who HAVE the disease from those who DO NOT.
Three components: Sensitivity, Specificity, Predictive Value
The 2×2 Table (Must memorise)
DISEASE
Present Absent
TEST Positive a b (a+b)
Negative c d (c+d)
(a+c) (b+d) Total
- a = True Positives (TP)
- b = False Positives (FP)
- c = False Negatives (FN)
- d = True Negatives (TN)
Sensitivity
"The ability of a test to correctly identify those WHO HAVE the disease."
Formula: a / (a+c) × 100
- Sensitivity = TP / (TP + FN) × 100
- A highly sensitive test has few False Negatives
- Used when missing a case is dangerous (e.g., HIV, TB, cancer)
- "Snout" mnemonic: SnNout - Sensitive test, Negative result rules OUT disease
Specificity
"The ability of a test to correctly identify those WHO DO NOT have the disease."
Formula: d / (b+d) × 100
- Specificity = TN / (TN + FP) × 100
- A highly specific test has few False Positives
- Used when a false positive causes harm (e.g., unnecessary surgery, stigma)
- "Spin" mnemonic: SpPin - Specific test, Positive result rules IN disease
Key Trade-off
- Sensitivity and specificity are inversely related
- Raising the cut-off point → ↑ Specificity, ↓ Sensitivity
- Lowering the cut-off point → ↑ Sensitivity, ↓ Specificity
8. PREDICTIVE VALUE (Very High-Yield)
Positive Predictive Value (PPV)
"The probability that a person who tests positive ACTUALLY HAS the disease."
Formula: a / (a+b) × 100 = TP / (TP + FP)
Negative Predictive Value (NPV)
"The probability that a person who tests negative ACTUALLY DOES NOT HAVE the disease."
Formula: d / (c+d) × 100 = TN / (FN + TN)
Effect of Prevalence on Predictive Value
This is a VERY important concept:
- When prevalence is HIGH → PPV increases, NPV decreases
- When prevalence is LOW → PPV decreases (many false positives), NPV increases
- Same test in a high-prevalence population has a higher PPV than in a low-prevalence population
Clinical implication: A screening test that works well in a high-risk population may give mostly false positives if applied to the general low-risk population. This is why selective/targeted screening is often preferred.
9. RELIABILITY (REPRODUCIBILITY / PRECISION)
Definition: The ability of a test to give consistent results on repeated trials under the same conditions.
A test can be reliable but not valid (consistently wrong).
A test cannot be valid but not reliable (if valid, it must also be reliable).
Sources of variation reducing reliability:
A. Observer variation
- Intra-observer variation: Same observer gets different results on repeat measurement
- Inter-observer variation: Two different observers get different results
- Occurs in: reading X-rays, interpreting cervical smears, auscultation of BP
- Minimized by: standardization of procedures, intensive training, using ≥2 independent observers
B. Biological (subject) variation
- Changes in the parameter itself: e.g., cervical smear may be normal one day, abnormal another; BP varies through the day
- Variation in how patients perceive/answer: recall errors, deliberate concealment
- Regression to the mean: Extreme values tend to move toward the average on re-measurement. Important when evaluating drug therapy (e.g., antihypertensives) - improvement may be partly regression to mean, not true drug effect
C. Technical method errors
- Defective instruments, erroneous calibration, faulty reagents
- Test itself may be inappropriate or unreliable
10. DISTRIBUTION OF VARIABLES - The Cut-Off Point
Bimodal Distribution
- Two separate curves: one for "normal" population, one for "diseased"
- Clear separation with a "borderline" zone where the curves overlap
- Cut-off point set at point E (where distributions intersect) minimizes both false positives and false negatives
- Example: Phenylketonuria (PKU)
Unimodal Distribution
- Single continuous curve (e.g., blood pressure, blood sugar, serum cholesterol)
- No sharp dividing line between normal and diseased
- Cut-off point is arbitrary
- Cutting at level C/A (lower) → Higher sensitivity, more false positives
- Cutting at level D/B (higher) → Higher specificity, more false negatives
- Example: Diabetes (blood glucose cut-off)
11. EVALUATION OF SCREENING PROGRAMMES
A screening programme should be evaluated for:
- Yield - number of new cases detected in the screened population
- Sensitivity and Specificity of the test used
- Predictive value in the target population
- Cost-effectiveness - cost per case detected
- Compliance - uptake rate in the target population
- Follow-up - proportion of screen-positives who receive definitive diagnosis and treatment
- Impact - reduction in morbidity/mortality in the screened group vs. unscreened
Factors affecting yield:
- Prevalence of unrecognized disease in the population
- Sensitivity of the test
- Number of persons tested
12. BIAS IN SCREENING (High-Yield Exam Topic)
Lead Time Bias
- Screening detects disease earlier in its natural history
- Survival appears longer from diagnosis - but this is just because diagnosis was moved earlier, not because the patient actually lived longer
- This can make a screening programme appear effective when it is not
Length Bias
- Screening tends to detect slower-progressing (less aggressive) cases, because they spend more time in the detectable pre-clinical phase
- Rapidly progressive (aggressive) cases pass through the detectable phase quickly and are missed
- Result: Screened cases appear to have better outcomes than unscreened cases, even if screening has no real benefit
Selection Bias (Volunteer Bias)
- People who participate in screening tend to be more health-conscious, and thus have better outcomes regardless of screening
- Makes screening appear more effective than it is
13. SOME SPECIFIC SCREENING TESTS (from Table 8 in Park's)
| Disease | Screening Test |
|---|
| Tuberculosis | Tuberculin test, Chest X-ray, sputum smear |
| Hypertension | BP measurement |
| Diabetes mellitus | Urine glucose (glycosuria), Random/Fasting blood glucose, OGTT |
| Cervical cancer | Pap smear (Papanicolaou smear) |
| Breast cancer | Self-examination, clinical breast exam, mammography |
| PKU | Guthrie test (blood phenylalanine) |
| Hypothyroidism | TSH (heel-prick blood spot) |
| Anaemia | Haemoglobin / PCV |
| Syphilis | VDRL |
| Gonorrhoea | Endocervical culture |
| Glaucoma | Tonometry |
| Deafness | Audiometry |
| Visual defects | Snellen chart |
| Neural tube defects (prenatal) | Maternal serum AFP |
14. CANCER SCREENING (from Park's block 6)
Key principles:
- Cancer screening is most useful when a detectable pre-clinical phase exists
- Must have an effective treatment that improves outcomes when applied early
- Most evidence-based cancer screening programmes:
- Cervical cancer: Pap smear (every 3 years from age 21, or HPV co-testing every 5 years)
- Breast cancer: Mammography (annual/biennial from age 40-50 depending on guideline)
- Colorectal cancer: Faecal occult blood test (FOBT), colonoscopy
- Oral cancer: Visual inspection with naked eye / acetic acid (VIA)
15. NEONATAL SCREENING
Purpose: Detect inborn errors of metabolism before symptoms appear, when treatment can prevent disability.
Conditions screened (Indian national programme):
- Congenital hypothyroidism (CHT) - most common
- Phenylketonuria (PKU)
- G6PD deficiency
- Congenital adrenal hyperplasia (CAH)
- Sickle cell disease
Method: Heel-prick blood spot on filter paper (Guthrie card) collected at 48-72 hours after birth.
Treatment:
- CHT: Thyroxine supplementation (prevents cretinism)
- PKU: Phenylalanine-restricted diet (prevents intellectual disability)
QUICK REVISION FLASHCARDS
Q: Define screening.
A: Search for unrecognized disease/defect by rapidly applied tests in apparently healthy individuals.
Q: What are the 3 types of screening?
A: Mass (whole population), Selective/High-risk (targeted group), Multiphasic (multiple tests simultaneously).
Q: Sensitivity formula?
A: TP / (TP + FN) × 100. It identifies TRUE POSITIVES correctly.
Q: Specificity formula?
A: TN / (TN + FP) × 100. It identifies TRUE NEGATIVES correctly.
Q: Sensitive test negative → ?
A: Rules OUT disease (SnNout).
Q: Specific test positive → ?
A: Rules IN disease (SpPin).
Q: When prevalence rises, what happens to PPV?
A: PPV rises. NPV falls.
Q: What is lead-time bias?
A: Earlier diagnosis appears to prolong survival but the patient doesn't actually live longer - just diagnosed earlier.
Q: What is multiphasic screening?
A: Two or more screening tests applied simultaneously to a large population.
Q: What is regression to the mean?
A: Extreme values tend to move toward the average on repeat measurements - important to remember when evaluating therapy effectiveness.
Q: Prospective vs. Prescriptive screening?
A: Prospective = for benefit of others (e.g., screening immigrants for TB). Prescriptive = for benefit of the individual (e.g., neonatal screening).
Q: Wilson & Jungner - how many criteria?
A: 9 criteria. Key ones: important health problem, accepted treatment available, recognizable latent stage, suitable/acceptable test, facilities available, cost balanced, continuing process.
HIGH-YIELD MCQ TRAPS
- Screening is not a diagnostic test - screen positives need further workup
- A highly sensitive test is preferred for serious diseases where missing a case is dangerous
- A highly specific test is preferred where a false positive causes harm (unnecessary surgery, stigma)
- Reliability ≠ Validity - a test can be reliable (reproducible) but invalid (consistently wrong)
- PPV depends heavily on prevalence - the same test has a lower PPV in low-prevalence settings
- Multiphasic screening is the most cost-effective strategy per person screened
- The Guthrie test is the screening test for PKU
- Pap smear is the screening test for cervical cancer (not diagnosis)
- Lead time bias overestimates benefit of screening by shifting apparent survival without real benefit
- In bimodal distribution, cut-off at intersection point (E) minimizes misclassification
This covers every topic in the screening chapter of Park's - from the concept, through types and criteria, to validity/reliability statistics, bias, specific programme tests, neonatal screening, and cancer screening. Focus especially on the 2×2 table formulas (sensitivity, specificity, PPV, NPV), the Wilson & Jungner criteria, and the three types of bias - these are the highest-yield exam areas.